Attached files

file filename
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - BIOMET INCdex312.htm
EX-32.1 - CERTIFICATION TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 - BIOMET INCdex321.htm
10-Q - FORM 10-Q - BIOMET INCd10q.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - BIOMET INCdex311.htm

Exhibit 12

Biomet, Inc.

Computation of Ratio of Earnings to Fixed Charges

(in millions, except ratios)

 

     Successor          Predecessor
     Nine Months Ended
February 28,
    Period From
July 12, 2007  -

May 31, 2008
         Period From
June 1, 2007  -

July 11, 2007
    Years Ended May 31,
     2010     2009              2007    2006    2005    2004

Earnings:

                       

Earnings (loss) before income taxes

   $ (97.4   $ (684.0   $ (1,194.3       $ (81.9   $ 501.6    $ 611.0    $ 546.5    $ 500.7
 

Add: Fixed charges (per below)

     389.6        483.9        603.1            0.3        9.3      11.7      9.2      4.2
 

Total earnings (loss)

   $ 292.2      $ (200.1   $ (591.2       $ (81.6   $ 510.9    $ 622.7    $ 555.7    $ 504.9
 

Fixed charges:

                       

Interest expense(2)

   $ 389.6      $ 483.9      $ 603.1          $ 0.3      $ 9.3    $ 11.7    $ 9.2    $ 4.2
                                                               

Total fixed charges

   $ 389.6      $ 483.9      $ 603.1          $ 0.3      $ 9.3    $ 11.7    $ 9.2    $ 4.2
                                                               

Ratio of earnings to fixed charges

     0.8        N/A (1)      N/A (1)          N/A (1)      54.9      53.2      60.4      120.2

 

(1) Earnings were inadequate to cover fixed charges for the nine months ended February 28, 2009, for the period July 12, 2007 through May 31, 2008, and for the period June 1, 2007 through July 11, 2007 by $684.0 million, $1,194.3 million, and $81.9 million, respectively.
(2) Interest expense includes the amortization of deferred financing costs and bond premium.